1. Home
  2. INSM
  3. INSM News

Latest Insmed Incorporated (INSM) News on April 2, 2025

Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts
INSM

Insider Monkey

7 days ago

Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts

Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
INSM

PR Newswire

8 days ago

Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference

Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires
INSM

Insider Monkey

15 days ago

Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

23 days ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INSM

MT Newswires

a month ago

UBS Adjusts Price Target on Insmed to $110 From $105, Maintains Buy Rating

INSM

MT Newswires

a month ago

Insmed Insider Sold Shares Worth $1,989,797, According to a Recent SEC Filing

INSM

MT Newswires

a month ago

Insmed to Benefit From Strong Launch of Brensocatib for Lung Disease, RBC Says

INSM

MT Newswires

a month ago

RBC Capital Initiates Insmed at Outperform With $100 Price Target

International Markets and Insmed (INSM): A Deep Dive for Investors
INSM

Zacks

a month ago

International Markets and Insmed (INSM): A Deep Dive for Investors

Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
INSM

PR Newswire

a month ago

Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis

INSM

MT Newswires

a month ago

UBS Adjusts Insmed Price Target to $105 From $84, Maintains Buy Rating

INSM

MT Newswires

a month ago

Truist Securities Adjusts Insmed Price Target to $108 From $105, Maintains Buy Rating

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates
INSM

Zacks

a month ago

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Full Year 2024 Earnings: EPS Misses Expectations
INSM

Simply Wall St.

a month ago

Insmed Full Year 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
INSM

GuruFocus.com

a month ago

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

INSM

MT Newswires

a month ago

Insmed Insider Sold Shares Worth $1,471,394, According to a Recent SEC Filing

INSM

MT Newswires

a month ago

Insmed Insider Sold Shares Worth $2,072,721, According to a Recent SEC Filing

Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say
INSM

Zacks

a month ago

Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say

INSM

MT Newswires

a month ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates
INSM

Zacks

a month ago

Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates

INSM

Associated Press Finance

a month ago

Insmed: Q4 Earnings Snapshot

INSM

MT Newswires

a month ago

Insmed's Q4 Loss Widens, Revenue Rises

Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
INSM

PR Newswire

a month ago

Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?
INSM

Insider Monkey

a month ago

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

INSM

MT Newswires

a month ago

Mizuho Adjusts Price Target on Insmed to $96 From $88, Keeps Outperform Rating

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?
INSM

Zacks

a month ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics
INSM

Zacks

a month ago

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,465,680, According to a Recent SEC Filing

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
INSM

Zacks

2 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Insmed To Present at March 2025 Investor Conferences
INSM

PR Newswire

2 months ago

Insmed To Present at March 2025 Investor Conferences

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
INSM

PR Newswire

2 months ago

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025

INSM

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 02/10/2025

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,670,585, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $2,296,751, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $640,708, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $6,419,415, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $3,697,402, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,901,150, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $2,678,925, According to a Recent SEC Filing

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review
INSM

Zacks

2 months ago

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

2 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INSM

MT Newswires

2 months ago

Insmed Says Brensocatib Application for Lung Disease Gets FDA Priority Review

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
INSM

PR Newswire

2 months ago

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025

INSM

MT Newswires

2 months ago

Morgan Stanley Raises Price Target on Insmed to $90 From $85, Keeps Overweight Rating

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,993,731, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $7,291,200, According to a Recent SEC Filing

Gene therapies have been uneven for DMD — but these companies hope to turn the tide
INSM

Pharma Voice

2 months ago

Gene therapies have been uneven for DMD — but these companies hope to turn the tide

The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing
INSM

Simply Wall St.

2 months ago

The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?
INSM

Insider Monkey

2 months ago

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?

INSM

MT Newswires

3 months ago

Insmed Insider Sold Shares Worth $2,711,456, According to a Recent SEC Filing

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance
INSM

Pharmaceutical Technology

3 months ago

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance

Why INSM Stock Is Advancing Today
INSM

Insider Monkey

3 months ago

Why INSM Stock Is Advancing Today

INSM

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 01/13/2025

INSM

MT Newswires

3 months ago

Insmed Says Full-year Revenue Expected to Rise 19%

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
INSM

PR Newswire

3 months ago

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

INSM

MT Newswires

3 months ago

Insmed Insider Sold Shares Worth $1,786,644, According to a Recent SEC Filing

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

3 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference
INSM

PR Newswire

3 months ago

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?
INSM

Insider Monkey

3 months ago

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?
INSM

Insider Monkey

3 months ago

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

5 Biotech Breakthrough Stocks to Watch in 2025
INSM

Zacks

3 months ago

5 Biotech Breakthrough Stocks to Watch in 2025

Should You Invest in Insmed Incorporated (INSM)?
INSM

Insider Monkey

4 months ago

Should You Invest in Insmed Incorporated (INSM)?

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
INSM

Zacks

4 months ago

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

4 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?
INSM

Zacks

4 months ago

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?
INSM

Insider Monkey

4 months ago

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insmed To Present at December 2024 Investor Conferences
INSM

PR Newswire

4 months ago

Insmed To Present at December 2024 Investor Conferences

INSM

MT Newswires

4 months ago

Sector Update: Health Care Stocks Decline

INSM

MT Newswires

4 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

INSM

MT Newswires

4 months ago

Insmed Terminates $500 Million Share Sale Agreement With Leerink

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

5 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at November 2024 Investor Conferences
INSM

PR Newswire

5 months ago

Insmed To Present at November 2024 Investor Conferences

Insmed (INSM) Reliance on International Sales: What Investors Need to Know
INSM

Zacks

5 months ago

Insmed (INSM) Reliance on International Sales: What Investors Need to Know

Do You Believe in the Growth Potential of Insmed (INSM)?
INSM

Insider Monkey

5 months ago

Do You Believe in the Growth Potential of Insmed (INSM)?

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates
INSM

Zacks

5 months ago

Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations
INSM

Simply Wall St.

5 months ago

Insmed Third Quarter 2024 Earnings: EPS Misses Expectations

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
INSM

GuruFocus.com

5 months ago

Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

INSM

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Insmed Inc Earnings Call

Decoding Insmed Inc (INSM): A Strategic SWOT Insight
INSM

GuruFocus.com

5 months ago

Decoding Insmed Inc (INSM): A Strategic SWOT Insight

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say
INSM

Zacks

5 months ago

Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say

INSM

MT Newswires

5 months ago

Insmed Q3 Net Loss Widens, Revenue Rises

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
INSM

Zacks

5 months ago

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates

INSM

Associated Press Finance

5 months ago

Insmed: Q3 Earnings Snapshot

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
INSM

PR Newswire

5 months ago

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
INSM

Zacks

5 months ago

Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

How to play biotech stocks: Insmed and Wave Life Sciences
INSM

Yahoo Finance Video

5 months ago

How to play biotech stocks: Insmed and Wave Life Sciences

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
INSM

PR Newswire

5 months ago

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
INSM

Zacks

5 months ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
INSM

PR Newswire

5 months ago

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
INSM

Zacks

6 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
INSM

PR Newswire

6 months ago

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024

INSM

MT Newswires

6 months ago

Truist Securities Raises Insmed's Price Target to $100 From $85, Buy Rating Maintained

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
INSM

GuruFocus.com

6 months ago

Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
INSM

Zacks

6 months ago

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?

INSM

MT Newswires

6 months ago

Insmed Reports Consistent Subgroup Data in Phase 3 Study of Brensocatib With Overall Trial Results

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
INSM

PR Newswire

6 months ago

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
INSM

Insider Monkey

6 months ago

Insmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

6 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?
INSM

Insider Monkey

6 months ago

Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?
INSM

Insider Monkey

6 months ago

Is Insmed Inc. (INSM) the Best Performing Stock in 2024?

Share on Social Networks: